Delaware
|
84-0448400
|
|||
(State
or other jurisdiction of
|
(I.R.S.
Employer
|
|||
incorporation
or organization)
|
Identification
Number)
|
PART
I
|
FINANCIAL
INFORMATION
|
2
|
|
ITEM
1.
|
FINANCIAL
STATEMENTS
|
2
|
|
ITEM
2.
|
MANAGEMENT’S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATION
|
21
|
|
ITEM
3.
|
CONTROLS
AND PROCEDURES
|
29
|
|
PART
II
|
OTHER
INFORMATION
|
30
|
|
ITEM
1.
|
LEGAL
PROCEEDINGS
|
30
|
|
ITEM
2.
|
UNREGISTERED
SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
|
30
|
|
ITEM
3.
|
DEFAULTS
UPON SENIOR SECURITIES
|
30
|
|
ITEM
4.
|
SUBMISSION
OF MATTERS TO A VOTE OF SECURITY HOLDERS
|
30
|
|
ITEM
5.
|
OTHER
INFORMATION
|
30
|
|
ITEM
6.
|
EXHIBITS
AND REPORTS ON FORM 8-K
|
31
|
|
SIGNATURES
|
35
|
September
30,
|
December 31, | ||||||
2006
|
2005
|
||||||
(unaudited)
|
|||||||
ASSETS
|
|||||||
Current
assets
|
|||||||
Cash
and cash equivalents
|
$
|
167,009
|
$
|
14,576
|
|||
Accounts
receivable, net of allowance for doubtful account $87,219 and $ 82,942
as
at September 30, 2006 and December 31, 2005, respectively
|
247,882
|
701,486
|
|||||
Inventories,
net of allowance of inventory impairment $48,271 and nil as at September
30, 2006 and December 31, 2005, respectively
|
538,274
|
495,597
|
|||||
Prepaid
expenses
|
541,733
|
1,962
|
|||||
Other
current assets
|
65,371
|
27,186
|
|||||
Total
Current Assets
|
1,560,269
|
1,240,807
|
|||||
Property
plant and equipment:
|
|||||||
Buildings
|
1,032,889
|
1,012,219
|
|||||
Machinery
and equipment
|
577,881
|
447,361
|
|||||
Automobiles
|
106,036
|
103,914
|
|||||
Office
equipment
|
67,740
|
57,423
|
|||||
Computer
software
|
9,123
|
8,940
|
|||||
|
1,793,669
|
1,629,857
|
|||||
Less:
Accumulated depreciation
|
(280,111
|
)
|
(192,991
|
)
|
|||
Property
plant and equipment - net
|
1,513,558
|
1,436,866
|
|||||
Construction
in progress
|
34,111
|
33,429
|
|||||
Intangible
assets-net
|
374,609
|
410,586
|
|||||
Deferred
financing cost
|
45,695
|
-
|
|||||
Deposit
to buy the technology for development of products
|
126,443
|
-
|
|||||
Total
assets
|
$
|
3,654,685
|
$
|
3,121,688
|
|||
LIABILITIES
AND STOCKHOLDERS' DEFICIENCY
|
|||||||
Current
Liabilities
|
|||||||
Accounts
payable and accrued expenses
|
$
|
1,016,319
|
$
|
1,000,477
|
|||
Construction
costs payable
|
366,032
|
372,338
|
|||||
Due
to related parties
|
11,635
|
454,193
|
|||||
Convertible
notes payable
|
100,000
|
407,135
|
|||||
Current
portion of bank notes payable
|
14,289
|
13,647
|
|||||
Total
current liabilities
|
1,508,275
|
2,247,790
|
|||||
Long-term
liabilities, less current portion:
|
|||||||
Unsecured
loans payable
|
1,454,095
|
1,424,996
|
|||||
Bank
notes payable
|
6,910
|
13,895
|
|||||
Long-term
convertible notes payable
|
1,592,500
|
-
|
|||||
Discount
on fair value of warrants in connection with
long-term
convertible notes
|
(929,030
|
)
|
-
|
||||
Total
long-term liabilities
|
2,124,475
|
1,438,891
|
|||||
Minority
interest in subsidiary
|
120,134
|
-
|
|||||
Shareholders'
Deficiency
|
|||||||
Common
stock -$0.001 par value Authorized
200,000,000 and 100,000,000 shares at September
30, 2006 and December 31, 2005, respectively issued
and outstanding 64,785,930 and 59,235,930 shares at September 30,
2006 and
December 31, 2005, respectively
|
64,786
|
59,236
|
|||||
Preferred
stock -$0.001 par value Authorized 20,000,000 shares at September
30, 2006
and December 31, 2005 issued and outstanding no shares at September
30,
2006 and December 31, 2005
|
-
|
-
|
|||||
Additional
paid-in capital
|
6,751,704
|
4,835,968
|
|||||
Stock-based
compensation reserve
|
(139,677
|
)
|
-
|
||||
Deficit
accumulated
|
(6,825,726
|
)
|
(5,482,555
|
)
|
|||
Accumulated
other comprehensive income
|
50,714
|
22,358
|
|||||
Total
stockholders' deficiency
|
(98,199
|
)
|
(564,993
|
)
|
|||
Total
liabilities and stockholders' deficiency
|
$
|
3,654,685
|
$
|
3,121,688
|
Kiwa
Bio-Tech Products Group Corporation and
Subsidiaries
|
|||||||||||||
Condensed
Consolidated Statements of Operations and Comprehensive Income (Unaudited)
|
|||||||||||||
Three
months ended September 30,
|
Nine
months ended September 30,
|
||||||||||||
|
2006
|
2005
|
2006
|
2005
|
|||||||||
Net
sales
|
906,068
|
$
|
3,422
|
$
|
930,442
|
$
|
1,021,725
|
||||||
Cost
of sales
|
852,885
|
5,521
|
872,840
|
286,439
|
|||||||||
Gross
profit
|
53,183
|
($2,099
|
)
|
$
|
57,602
|
$
|
735,286
|
||||||
Operating
expenses:
|
|||||||||||||
Consulting
and professional fees
|
244,566
|
153,634
|
532,880
|
500,031
|
|||||||||
Officers'
compensation
|
48,381
|
7,864
|
163,451
|
32,846
|
|||||||||
General
and administrative
|
207,606
|
115,255
|
375,991
|
477,389
|
|||||||||
Research
and development
|
46,891
|
1,617
|
63,253
|
10,040
|
|||||||||
Depreciation
and amortization
|
23,060
|
22,620
|
93,291
|
73,809
|
|||||||||
Allowance
and provision
|
48,039
|
-
|
51,138
|
-
|
|||||||||
Total
costs and expenses
|
618,543
|
300,990
|
1,280,004
|
1,094,115
|
|||||||||
Operating
loss:
|
(565,360
|
)
|
(303,089
|
)
|
(1,222,402
|
)
|
(358,829
|
)
|
|||||
Interest
expense, net
|
(70,784
|
)
|
(130,444
|
)
|
(120,635
|
)
|
(264,690
|
)
|
|||||
Other
income
|
-
|
-
|
-
|
2,416
|
|||||||||
Minority
interest in subsidiary
|
(134
|
)
|
-
|
(134
|
)
|
-
|
|||||||
Net
loss
|
($636,278
|
)
|
($433,533
|
)
|
($1,343,171
|
)
|
($621,103
|
)
|
|||||
Other
comprehensive income:
|
|||||||||||||
Translation
adjustment
|
12,159
|
25,101
|
28,356
|
25,101
|
|||||||||
Comprehensive
loss
|
($624,119
|
)
|
($408,432
|
)
|
($1,314,815
|
)
|
($596,002
|
)
|
|||||
Net
loss per common share-
basic and diluted
|
(0.010
|
)
|
(0.008
|
)
|
(0.022
|
)
|
(0.013
|
)
|
|||||
Weighted
average number of common shares-
basic and diluted
|
64,565,278
|
54,846,674
|
61,801,131
|
48,168,361
|
Kiwa
Bio-Tech Products Group Corporation
Consolidated
Statement of Stockholders' Deficiency
|
||||||||||||||||||||||
Common
Stock
|
||||||||||||||||||||||
Shares
|
Amount
|
Additional
Paid-in
Capital
|
Stock-based
Compensation Reserve
|
Accumulated
Deficits
|
Other
Comprehensive income
|
Total
Stockholders’
Deficiency
|
||||||||||||||||
Balance,
January 1, 2006
|
59,235,930
|
59,236
|
4,835,968
|
- |
(5,482,555
|
)
|
22,358
|
(564,993
|
)
|
|||||||||||||
Issuance
of detachable warrants in conjunction with the advances from a related
party dated March 31, 2006
|
-
|
-
|
5,145
|
-
|
-
|
-
|
5,145
|
|||||||||||||||
Issuance
of 5 million shares of common stock pursuant to the Stock Purchase
Agreement dated as of March 10, 2006
|
5,000,000
|
5,000
|
740,416
|
-
|
-
|
-
|
745,416
|
|||||||||||||||
Issuance
of detachable warrants in conjunction with the issuance of convertible
promissory notes on June 29, 2006 and August 15, 2006
|
-
|
-
|
962,453
|
-
|
-
|
-
|
962,453
|
|||||||||||||||
Issuance
of warrants to a financing consultant in June and August 2006
|
-
|
-
|
152,920
|
(139,677
|
)
|
-
|
-
|
13,243
|
||||||||||||||
Fair
value of shares as compensation to an employee
|
- | - |
46,352
|
-
|
-
|
-
|
46,352
|
|||||||||||||||
Issuance
of common stock for exercise of warrants at July 6, 2006
|
50,000
|
50
|
(50
|
)
|
-
|
-
|
-
|
-
|
||||||||||||||
Issuance
of common stock for exercise of warrants at August 9, 2006
|
500,000
|
500
|
8,500
|
-
|
-
|
-
|
9,000
|
|||||||||||||||
Net
loss for nine months ended September 30, 2006
|
-
|
-
|
-
|
-
|
(1,343,171
|
)
|
-
|
(1,343,171
|
)
|
|||||||||||||
Other
comprehensive income-Translation
adjustment
|
-
|
-
|
-
|
-
|
-
|
28,356
|
28,356
|
|||||||||||||||
Balance,
September 30, 2006
|
64,785,930
|
64,786
|
6,751,704
|
(139,677
|
)
|
(6,825,726
|
)
|
50,714
|
(98,199
|
)
|
Kiwa
Bio-Tech Products Group Corporation and
Subsidiaries
|
|||||||
Consolidated
Statements of Cash Flows
|
|||||||
Nine
months Ended
|
|||||||
September
30,
|
|||||||
|
2006
|
2005
|
|||||
Cash
flows from operating activities:
|
|||||||
Net
loss
|
($1,343,171
|
)
|
($621,103
|
)
|
|||
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
|||||||
Depreciation
and amortization
|
127,404
|
112,041
|
|||||
Amortization
of detachable warrants
|
52,644
|
74,038
|
|||||
Amortization
of beneficial conversion feature of convertible notes
|
-
|
106,666
|
|||||
Provision
for doubtful debt
|
51,138
|
-
|
|||||
Fair
value of shares as compensation to an employee
|
46,352
|
-
|
|||||
Minority
interest in subsidiary
|
134
|
-
|
|||||
Changes
in operating assets and liabilities:
|
|||||||
Accounts
receivable
|
450,505
|
(304,846
|
)
|
||||
Inventories
|
(90,716
|
)
|
(362,860
|
)
|
|||
Other
receivable
|
-
|
157,495
|
|||||
Prepaid
expenses
|
(539,771
|
)
|
113,617
|
||||
Other
current assets
|
(38,185
|
)
|
(11,571
|
)
|
|||
Deferred
financing cost
|
(50,000
|
)
|
-
|
||||
Deposit
|
(126,443
|
)
|
-
|
||||
Accounts
payable and accrued expenses
|
15,841
|
315,503
|
|||||
Construction
cost payable
|
(13,909
|
)
|
-
|
||||
Net
cash used in operating activities
|
(1,458,177
|
)
|
(421,020
|
)
|
|||
Cash
flows from investing activities:
|
|||||||
Purchase
of property and equipment
|
(9,144
|
)
|
(229,187
|
)
|
|||
Acquisition
of intangible asset
|
-
|
-
|
|||||
Net
cash used in investing activities
|
(9,144
|
)
|
(229,187
|
)
|
|||
Cash
flows from financing activities:
|
|||||||
Proceeds
from issuance of common stock
|
754,416
|
-
|
|||||
Repayment
of short-term loans
|
-
|
(50,000
|
)
|
||||
Proceeds
from related parties
|
106,318
|
321,337
|
|||||
Repayment
to related parties
|
(553,942
|
)
|
-
|
||||
Proceeds
from convertible notes payable
|
-
|
720,000
|
|||||
Repayment
of convertible notes payable
|
(307,135
|
)
|
(350,000
|
)
|
|||
Proceeds
from long-term convertible notes payable
|
1,592,500
|
-
|
|||||
Repayment
of long-term borrowings
|
(6,904
|
)
|
(6,388
|
)
|
|||
Net
cash provided by financing activities
|
1,585,253
|
634,949
|
|||||
Foreign
currency translation
|
34,501
|
13,322
|
|||||
Cash
and cash equivalents:
|
|||||||
Net
increase
|
152,433
|
(1,936
|
)
|
||||
Balance
at beginning of period
|
14,576
|
17,049
|
|||||
Balance
at end of period
|
$
|
167,009
|
$
|
15,113
|
|||
Supplemental
Disclosures of Cash flow Information:
|
|||||||
Cash
paid for interest
|
$
|
34,014
|
$
|
22,775
|
|||
Cash
paid for taxes
|
-
|
-
|
|||||
Non-cash
investing and financing activities:
|
|||||||
Fixed
assets invested by minority shareholder of subsidiary
|
$
|
120,000
|
-
|
||||
Beneficial
conversion feature of convertible notes payable
|
-
|
-
|
|||||
Issuance
of common stock for convertible notes payable
|
-
|
$
|
320,000
|
||||
Issuance
of detachable warrants in conjunction with issuance of
convertible notes payable
|
$
|
962,453
|
-
|
||||
Stock-based
compensation reserve
|
$
|
153,625
|
-
|
1.
|
Background
and Basis of Presentation
|
Buildings
|
20-35
years
|
|
Machinery
and equipments
|
4 -12 years | |
Automobiles
|
8
years
|
|
Office
equipment
|
5
years
|
|
Computer
software
|
3
years
|
2.
|
Recent
Accounting Pronouncements
|
3.
|
Inventories
|
|
September
30, 2006
|
December
31, 2005
|
|||||
|
(unaudited)
|
|
|||||
Raw
materials
|
$
|
420,184
|
$
|
417,237
|
|||
Semi-Finished
goods
|
7,259
|
||||||
Finished
goods
|
110,831
|
78,360
|
|||||
Total
|
$
|
538,274
|
$
|
495,597
|
4.
|
Prepaid
expenses
|
|
Note
|
September
30, 2006
|
December
31, 2005
|
|||||||
|
|
(unaudited)
|
|
|||||||
Prepaid
charges relating to urea entrepot trade
|
(i)
|
|
$
|
424,671
|
-
|
|||||
Prepaid
financing commission
|
(ii)
|
|
116,484
|
-
|
||||||
Prepaid
insurance premium
|
-
|
892
|
||||||||
Others
|
578
|
1,070
|
||||||||
|
$
|
541,733
|
$
|
1,962
|
5.
|
Property,
Plant and Equipment
|
6.
|
Intangible
Asset
|
Expected
Amortization
Period
|
Gross
Carrying
Value
|
Accumulated
Amortization
|
Intangible
Asset,
Net
|
||||||||||
Patent
|
8.5
years
|
$
|
480,411
|
$
|
105,802
|
$
|
374,609
|
Amount | |||||
2006
|
$
|
14,130
|
|||
2007
|
58,505
|
||||
2008
|
58,505
|
||||
2009
|
58,505
|
||||
2010
|
58,505
|
||||
Thereafter
|
126,460
|
||||
|
$
|
374,609
|
7.
|
Deposit
|
8.
|
Accounts
Payable and Accrued
Expenses
|
Item
|
September
30, 2006
|
December
31, 2005
|
|||||
(Unaudited)
|
|||||||
Consulting
and professional payables
|
$
|
424,335
|
$
|
411,360
|
|||
Payables
to material suppliers
|
99,371
|
211,903
|
|||||
Interest
payable
|
141,012
|
106,880
|
|||||
Salary
payable
|
112,822
|
92,557
|
|||||
Insurance
payable
|
87,589
|
81,553
|
|||||
Office
rental payable
|
50,171
|
39,007
|
|||||
Payables
to equipment suppliers
|
14,236
|
13,761
|
|||||
Others
|
86,783
|
43,456
|
|||||
Total
|
$
|
1,016,319
|
$
|
1,000,477
|
9.
|
Construction
Costs Payable
|
10.
|
Related
Party Transactions
|
Notes
|
September
30, 2006
(Unaudited)
|
December
31, 2005
|
||||||||
Mr.
Wei Li (“Mr. Li”)
|
(i)
|
|
$
|
5,132
|
$
|
191,861
|
||||
China
Star Investment Management Co. Ltd. (“China Star”)
|
(ii)
|
|
181
|
263,165
|
||||||
Tianjin
Challenge Feed Co. Ltd. (“Challenge Feed”)
|
(iii)
|
|
6,322
|
-
|
||||||
Total
|
$
|
11,635
|
$
|
454,193
|
11.
|
Convertible
Notes Payable
|
12.
|
Unsecured
loans payable
|
September
30, 2006
(Unaudited)
|
December
31, 2005
|
||||||
Unsecured
loan payable to Zoucheng Municipal
Government,
non-interest bearing, becoming due within three years from Kiwa Shandong’s
first profitable year on a formula basis, interest has not been imputed
due to the undeterminable repayment date
|
$
|
1,137,987
|
$
|
1,115,214
|
|||
Unsecured
loan payable to Zoucheng Science & Technology Bureau, non-interest
bearing, it is due in Kiwa Shandong’s first profitable year, interest has
not been imputed due to the undeterminable repayment date
|
316,018
|
309,782
|
|||||
Total
|
$
|
1,454,095
|
$
|
1,424,996
|
13.
|
Long-term
convertible notes payable
|
14.
|
Equity-Based
Transactions
|
15.
|
Segment
Reporting
|
Bio-fertilizer
|
Livestock
Feed
|
Corporate
|
Total
|
||||||||||
Three
months ended September 30, 2006
|
|||||||||||||
Net
sales
|
$
|
17,381
|
$
|
888,687
|
-
|
$
|
906,068
|
||||||
Gross
profit
|
6,333
|
46,850
|
-
|
53,183
|
|||||||||
Operating
expenses
|
216,676
|
46,188
|
355,679
|
618,543
|
|||||||||
Operating
profit (loss)
|
(210,343
|
)
|
662
|
(355,679
|
)
|
(565,360
|
)
|
||||||
Interest
(expense) income
|
(532
|
)
|
7
|
(70,259
|
)
|
(70,784
|
)
|
||||||
Minority
interest in subsidiary
|
(134
|
)
|
-
|
(134
|
)
|
||||||||
Net
income (loss)
|
(210,593
|
)
|
803
|
(426,488
|
)
|
(636,278
|
)
|
||||||
Three
months ended September 30, 2005
|
|||||||||||||
Net
sales
|
3,422
|
-
|
-
|
3,422
|
|||||||||
Gross
profit
|
(2,099
|
)
|
-
|
-
|
(2,099
|
)
|
|||||||
Operating
expenses
|
115,414
|
-
|
185,576
|
300,990
|
|||||||||
Operating
profit (loss)
|
(117,514
|
)
|
-
|
(186,476
|
)
|
(303,089
|
)
|
||||||
Interest
(expense) income
|
(4,039
|
)
|
-
|
(126,405
|
)
|
(130,444
|
)
|
||||||
Net
income (loss)
|
(121,553
|
)
|
-
|
(311,980
|
)
|
(433,533
|
)
|
||||||
Nine
months ended September 30, 2006
|
|||||||||||||
Net
sales
|
41,755
|
$
|
888,687
|
-
|
$
|
930,442
|
|||||||
Gross
profit
|
10,752
|
46,850
|
-
|
57,602
|
|||||||||
Operating
expenses
|
493,684
|
46,188
|
740,132
|
1,280,004
|
|||||||||
Operating
profit (loss)
|
(482,932
|
)
|
662
|
(740,132
|
)
|
(1,222,402
|
)
|
||||||
Interest
expense (income)
|
(9,337
|
)
|
7
|
(111,305
|
)
|
(120,635
|
)
|
||||||
Minority
interest in subsidiary
|
-
|
(134
|
)
|
-
|
(134
|
)
|
|||||||
Net
income (loss)
|
(493,051
|
)
|
803
|
(850,923
|
)
|
(1,343,171
|
)
|
||||||
Total
assets, as of September 30, 2006
|
2,360,253
|
495,664
|
798,768
|
3,654,685
|
|||||||||
Nine
months ended September 30, 2005
|
|||||||||||||
Net
sales
|
1,021,725
|
-
|
-
|
1,021,725
|
|||||||||
Gross
profit
|
735,286
|
-
|
-
|
735,286
|
|||||||||
Operating
expenses
|
426,754
|
-
|
667,361
|
1,094,115
|
|||||||||
Operating
profit (loss)
|
308,532
|
-
|
(667,361
|
)
|
(358,829
|
)
|
|||||||
Interest
expense (income)
|
(8,616
|
)
|
-
|
273,306
|
264,690
|
||||||||
Other
income
|
2,416
|
-
|
-
|
2,416
|
|||||||||
Net
income (loss)
|
302,333
|
-
|
(923,436
|
)
|
(621,103
|
)
|
|||||||
Total
assets, as of September 30, 2005
|
3,665,435
|
-
|
30,527
|
3,695,962
|
16.
|
Commitments
and Contingencies
|
Fiscal
year
|
Amount
|
|||
Remaining
3 months of 2006
|
$
|
37,287
|
||
2007
|
149,148
|
|||
2008
|
97,185
|
|||
2009
|
50,576
|
|||
Total
|
$
|
334,196
|
17.
|
Subsequent
event
|
Bio-fertilizer
|
Livestock
feed
|
Total
|
||||||||
Nine
months ended September 30, 2006
|
||||||||||
Net
sales
|
$
|
41,755
|
$
|
888,687
|
$
|
930,442
|
||||
Cost
of sales
|
31,003
|
841,837
|
872,840
|
|||||||
Gross
profit (loss)
|
10,752
|
46,850
|
57,602
|
|||||||
Gross
profit (loss) ratio
|
25.8
|
%
|
5.3
|
%
|
6.2
|
%
|
||||
Nine
months ended September 30, 2005
|
||||||||||
Revenue
|
$
|
1,021,725
|
$
|
-
|
$
|
1,021,725
|
||||
Cost
of sales
|
286,439
|
-
|
286,439
|
|||||||
Gross
profit
|
735,286
|
-
|
735,286
|
|||||||
Gross
profit ratio
|
72.0
|
%
|
0.0
|
%
|
72.0
|
%
|
Bio-fertilizer
|
Livestock
feed
|
Total
|
||||||||
Three
months ended September 30, 2006
|
||||||||||
Net
sales
|
$
|
17,381
|
$
|
888,687
|
$
|
906,068
|
||||
Cost
of sales
|
11,048
|
841,837
|
852,885
|
|||||||
Gross
profit (loss)
|
6,333
|
46,850
|
53,183
|
|||||||
Gross
profit (loss) ratio
|
36.4
|
%
|
5.3
|
%
|
5.9
|
%
|
||||
Three
months ended September 30, 2005
|
||||||||||
Revenue
|
$
|
3,422
|
$
|
-
|
$
|
3,422
|
||||
Cost
of sales
|
5,521
|
-
|
5,521
|
|||||||
Gross
profit (loss)
|
(2,099
|
)
|
-
|
(2,099
|
)
|
|||||
Gross
profit (loss) ratio
|
-
|
-
|
-
|
Exhibit
No.
|
Description
|
Incorporated
by
Reference
in
Document
|
Exhibit
No. in Incorporated Document
|
||
2.1
|
Agreement
and Plan of Merger, dated March 11, 2004, by and among Tintic Gold
Mining
Company, TTGM Acquisition Corporation, and Kiwa
Bio-Tech
Products Group Ltd.
|
Form
8-K filed on March 29, 2004
|
2.1
|
||
2.2
|
Agreement
and Plan of Merger, dated July 22, 2004, between Kiwa Bio-Tech Products
Group Corporation, a Utah corporation, and Kiwa Bio-Tech Products
Group
Corporation.
|
Form
8-K filed on July
23,
2004
|
2.1
|
||
3.1
|
Certificate
of Incorporation, effective as of July 21, 2004.
|
Form
8-K filed on July
23
2004
|
3.1
|
||
3.2
|
Bylaws,
effective as of July 22, 2004.
|
Form
8-K filed on July
23, 2004
|
3.2
|
||
3.3
|
Certificate
of Amendment to Certificate of Incorporation, effective as of September
27, 2006.
|
Filed
herewith.
|
|||
10.1
|
Standby
Equity Distribution Agreement, dated July 6, 2004, between Cornell
Capital
Partners, LP and Kiwa Bio-Tech Products Group Corporation.
|
Form
SB-2 filed on August 2, 2004
|
10.1
|
||
10.2
|
Placement
Agent Agreement, dated July 6, 2004, between Newbridge Securities
Corporation and Kiwa Bio-Tech Products Group Corporation.
|
Form
SB-2 filed on August 2, 2004
|
10.2
|
||
10.3
|
Registration
Rights Agreement, dated July 6, 2004, between Cornell Capital Partners,
LP
and Kiwa Bio-Tech Products Group Corporation.
|
Form
SB-2 filed on August 2, 2004
|
10.3
|
||
10.4
|
Warrant
Purchase
Agreement, dated March 12,
2004, issued to Westpark Capital, Inc.
|
Form
10-QSB filed on May 20, 2004
|
10.1
|
||
10.5
|
Convertible
Loan Agreement, dated January 25, 2004 between Kiwa Bio-tech Products
Group Ltd. and Kao Ming Investment Company
|
Form
10-QSB filed May 20, 2004
|
10.2
|
||
10.6
|
Convertible
Loan Agreement dated March 12, 2004 for $200,000 between Kiwa Bio-Tech
Products Group Corporation and Jzu Hsiang Trading Co.,
Ltd.
|
Form
10-QSB filed on August 20, 2004
|
10.1
|
||
10.7
|
Engagement
agreement between Kiwa Bio-Tech Products Group Corporation and Cinapsys
Inc. dated May 24, 2004
|
Form
10-QSB filed on August 20, 2004
|
10.3
|
||
10.8
|
Patent
Transfer Agreement dated April 12, 2004, between Kiwa Bio-Tech Products
(Shandong) Co., Ltd. and China Agricultural University.
|
Form
SB-2/A filed on October 8, 2004
|
10.5
|
||
10.9
|
Patent
Transfer Contract, dated April 12, 2004, between Kiwa Bio-Tech Products
Group Corporation and China Agricultural University
|
Form
SB-2/A filed on November 23, 2004
|
10.5
|
||
10.10
|
Contract
of Project of Venture Capital of Zoucheng Science & Technology Plan
(Contract No.: 2004) among KIWA Bio-Tech Products (Shandong) Company,
Science & Technology Bureau and Zoucheng Branch of China Commercial
Bank of ICBC dated April 2004.
|
Form
SB-2/A filed on October 8, 2004
|
10.6
|
||
10.11
|
Contract
of Project of Venture Capital of Zoucheng Science & Technology Plan
(Contract No. 2002) among KIWA Bio-Tech Products (Shandong) Company,
Zoucheng Science & Technology Bureau and Zoucheng Branch of China
Commercial Bank of ICBC dated November 2002.
|
Form
SB-2/A filed on October 8, 2004
|
10.7
|
Exhibit
No.
|
Description
|
Incorporated
by
Reference
in
Document
|
Exhibit
No. in Incorporated Document
|
||
10.12
|
Contract
of Project of Venture Capital of Zoucheng Science & Technology Plan
(Contract No. 2002) among KIWA Bio-Tech Products Group Limited, Zoucheng
Municipal People’s Government
Bureau
and Zoucheng Branch of China Commercial Bank of ICBC dated May 26,
2002.
|
Form
SB-2/A filed on November 23, 2004
|
10.7
|
||
10.13
|
PBC
Project Investment Agreement between KIWA Bio-Tech Products Group
Limited
and Zoucheng Municipal Government dated June 25, 2002
|
Form
10-KSB filed on April 13, 2005
|
10.13
|
||
10.14
|
Employment
Agreement dated March 18, 2003 between Kiwa Bio-Tech Products Group
and
Lian jun Luo
|
Form
SB-2/A filed on November 23, 2004
|
10.13
|
||
10.15
|
Employment
Agreement dated March 18, 2003 between Kiwa Bio-Tech Products Group
and
Bin Qu
|
Form
SB-2/A filed on November 23, 2004
|
10.14
|
||
10.16
|
Convertible
Loan Agreement dated October 20, 2003 between China Star Investment
Group
and Kiwa Bio-Tech Products Group Ltd., as amended by letter agreement
dated August 1, 2004
|
Form
SB-2/A filed on October 8, 2004
|
10.8
|
||
10.17
|
Loan
Agreement dated July 26, 2004 between China Star Investment Group
and Kiwa
Bio-Tech Products Group Corporation
|
Form
SB-2/A filed on November 23, 2004
|
10.15
|
||
10.18
|
Commercial
Lease Agreement dated April 1, 2004 between Kiwa Bio-Tech Products
Group
Corporation and China Star Investment Company.
|
Form
SB-2/A filed on October 8, 2004
|
10.10
|
||
10.19
|
Convertible
Note
Agreement dated September
23,
2004 among Kiwa Bio-Tech Products Group Corporation and Young San
Kim and
Song N. Bang
|
Form
10-QSB filed on November 15, 2004
|
10.4
|
||
10.20
|
Amendment,
dated April 7, 2005, to Convertible Note Agreement dated September
23,
2004 among Kiwa Bio-Tech Products Group Corporation and Young San
Kim and
Song N. Bang
|
Form
10-KSB filed on April 13, 2005
|
10.20
|
||
10.21
|
Common
Stock Warrant dated September 23, 2004, issued by Kiwa Bio-Tech Products
Group Corporation to Young San Kim
|
Form
10-QSB filed on November 15, 2004
|
10.5
|
||
10.22
|
Common
Stock Warrant dated September 23, 2004, issued by Kiwa Bio-Tech Products
Group Corporation to Song N. Bang
|
Form
10-QSB filed on November 15, 2004
|
10.6
|
||
10.23
|
Promissory
Note
of Kiwa Bio-Tech Products Group Corporation, principal amount
$400,000,
issued to Cornell Capital Partners, LP on January 4, 2005, as amended
by
letter agreements dated March 21, 2005 and April 5, 2005.
|
Form
10-KSB filed on April 13, 2005
|
10.23
|
||
10.24
|
Payment
Acknowledgment and Release, dated June 8, 2005, among Kiwa Bio-Tech
Products Group Corporation and Young San Kim and Song N.
Bang
|
Form
10-QSB filed on May 20, 2005
|
10.1
|
||
10.25
|
Advance
Agreement, dated May 23, 2005, between Kiwa Bio-Tech Products Group
Corporation and Mr. Wei Li.
|
Form
10-QSB filed August 15, 2005
|
10.2
|
||
10.26
|
Promissory
Note of Kiwa Bio-Tech Products Group Corporation, principal amount
$150,000, issued to Donald Worthly dated May 30, 2005, as amended
June 1,
2005.
|
Form
8-K filed on August 12, 2005
|
10.1
|
||
10.27
|
Promissory
Note of Kiwa Bio-Tech Products Group Corporation, principal amount
$70,000, issued to Gertrude Yip dated May 30, 2005, as
amended.
|
Form
8-K filed on August 12, 2005
|
10.2
|
Exhibit
No.
|
Description
|
Incorporated
by
Reference
in
Document
|
Exhibit
No. in Incorporated Document
|
||
10.28
|
Promissory
Note of Kiwa Bio-Tech Products Group Corporation, principal amount
$100,000, issued to Hiro Sugimura and Elaine Sugimura dated June
16,
2005.
|
Form
8-K filed on August 12, 2005
|
10.3
|
||
10.29
|
Advance
Agreement, dated June 29, 2005, between Kiwa Bio-Tech Products (Shandong)
Co. Ltd. and China Star Investment Management Co. Ltd.
|
Form
10-QSB filed on August 15, 2005
|
10.7
|
||
10.30
|
Advance
Agreement, dated September 30, 2005, between Kiwa Bio-Tech Products
(Shandong) Co. Ltd. and China Star Investment Management Co.
Ltd.
|
Form
10-QSB filed on November 21, 2005
|
10.1
|
||
10.31
|
Advance
Agreement, dated December 31, 2005, between Kiwa Bio-Tech Products
(Shandong) Co. Ltd. and China Star Investment Management Co.
Ltd.
|
Form
10-KSB filed April 17, 2006
|
10.31
|
||
10.32
|
Stock
Purchase Agreement dated March 10, 2006 between Kiwa Bio-Tech Products
Group Corporation and Guilian Li Ziyang Zong
|
Form
8-K filed on March 15, 2006
|
10.1
|
||
10.33
|
Termination
Agreement between Kiwa Bio-Tech Products Group Corporation and Cornell
Capital dated on March 31, 2006
|
Form
8-K filed on April 4, 2006
|
10.1
|
||
10.34
|
Supplementary
Agreement for Stock Purchase Agreement dated on April 13,
2006
|
Form
10-KSB filed on April 17, 2006
|
10.34
|
||
10.35
|
Supplementary
Agreement for Stock Purchase Agreement dated on May 12,
2006
|
Form
10-QSB filed on May 15, 2006
|
10.35
|
||
10.36
|
Advance
Agreement, dated March 31, 2006, between Kiwa Bio-Tech Products (Shandong)
Co. Ltd. and China Star Investment Management Co. Ltd.
|
Form
10-QSB filed on May 15, 2006
|
10.36
|
||
10.37
|
Technology
Transfer Agreement dated May 8, 2006, between Kiwa Bio-Tech Products
Group
Corporation and Jinan Kelongboao Bio-Tech Co., Ltd.
|
Form
8-K filed on May 8, 2006
|
10.1
|
||
10.38
|
Acquisition
Framework Agreement between the Company and Beijing Huasheng Medicine
Co.,
dated May 10, 2006
|
Form
8-K filed on May 8, 2006
|
10.2
|
||
10.39
|
Securities
Purchase Agreement, dated as of June 29, 2006 between Kiwa Bio-Tech
Products Group Corporation and AJW Partners, LLC, AJW Offshore, Ltd.,
AJW
Qualified Partners, LLC, New Millennium Capital Partners II, LLC,
Double U
Master Fund LP, and Nite Capital LP (collectively, the
“Purchasers”)
|
Form
8-K filed on July 5, 2006
|
10.01
|
||
10.40
|
Registration
Rights Agreement, dated as of June 29, 2006 between Kiwa Bio-Tech
Products
Group Corporation and the Purchasers
|
Form
8-K filed on July 5, 2006
|
10.02
|
||
10.41
|
Security
Agreement, dated as of June 29, 2006, between Kiwa Bio-Tech Products
Group
Corporation and the Purchasers
|
Form
8-K filed on July 5, 2006
|
10.03
|
||
10.42
|
Intellectual
Property Security Agreement, dated as of June 29, 2006, between Kiwa
Bio-Tech Products Group Corporation and the Purchasers
|
Form
8-K filed on July 5, 2006
|
10.04
|
||
10.43
|
Pledge
Agreement, dated as of June 29, 2006, among Kiwa Bio-Tech Products
Group
Corporation, Wei Li, and the Purchasers
|
Form
8-K filed on July 5, 2006
|
10.05
|
||
10.44
|
Form
of Callable Secured Convertible Note, dated as of June 29, 2006,
issued by
Kiwa Bio-Tech Products Group Corporation to the Purchasers
|
Form
8-K filed on July 5, 2006
|
10.06
|
||
10.45
|
Form
of Stock Purchase Warrant, dated as of June 29, 2006, issued by Kiwa
Bio-Tech Products Group Corporation to the Purchasers
|
Form
8-K filed on July 5, 2006
|
10.07
|
Exhibit
No.
|
Description
|
Incorporated
by
Reference
in
Document
|
Exhibit
No. in Incorporated Document
|
||
10.46
|
Contract
for Joint Venture dated July 11, 2006 between Kiwa Bio-Tech Products
Group
Corporation and Tianjin Challenge Feed Co., Ltd.
|
Form
8-K filed on July 14, 2006
|
10.01
|
||
10.47
|
Contract
for urea dated July 28, 2006 between Kiwa Bio-Tech Products Group
Ltd. and
China Hua Yang Roneo Corporation.
|
Form
8-K filed on August 2, 2006
|
10.1
|
||
10.48
|
Contract
for urea dated July 31, 2006 between Kiwa Bio-Tech Products Group
Ltd. and
Shengkui Technologies, Inc.
|
Form
8-K filed on August 2, 2006
|
10.2
|
||
10.49
|
Employment
Agreement dated July 31, 2006 between Kiwa Bio-Tech Products Group
Ltd.
and Wei Li
|
Form
8-K filed on August 7, 2006
|
10.1
|
||
10.50
|
Employment
Agreement dated July 31, 2006 between Kiwa Bio-Tech Products Group
Ltd.
and Lianjun Luo
|
Form
8-K filed on August 7, 2006
|
10.2
|
||
10.51
|
Employment
Agreement dated September 25, 2006 between Kiwa Bio-Tech Products
Group
Ltd. and Juhua Wang
|
Form
8-K/A filed on September 25, 2006
|
10.1
|
||
10.52
|
Amendment
to Registration Right Agreement dated as of October 31, 2006, by
and among
Kiwa
Bio-Tech Products Group Corporation and the Purchasers
|
Filed
herewith
|
|||
10.53
|
Contract
dated August 8, 2006, by and among Kiwa Bio-Tech Products Group Ltd.
and
UPB International Sourcing Limited
|
Filed
herewith
|
|||
10.54
|
Supplementary
Agreement, dated August 20, 2006, by and between Kiwa Bio-Tech Products
Group Ltd. and UPB International Sourcing Limited
|
Filed
herewith
|
|||
10.55
|
Short
Term Loan Agreement, dated as of October 23, 2006, by and among Kiwa
Bio-Tech Products (Shandong) Co., Ltd and China Star Investment Management
Co., Ltd.
|
Filed
herewith
|
|||
21
|
List
of Subsidiaries
|
Form
10-QSB filed on May 20, 2005
|
21
|
||
31.1
|
Certification
of Principal Executive Officer pursuant to Rule 13a-14(a)/15d-14(a)
of the
Securities Exchange Act of 1934
|
Filed
herewith.
|
|||
31.2
|
Certification
of Principal Financial Officer pursuant to Rule 13a-14(a)/15d-14(a)
of the
Securities Exchange Act of 1934
|
Filed
herewith.
|
|||
32.1
|
Certification
of Principal Executive Officer, pursuant to 18 U.S.C. 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
Filed
herewith.
|
|||
32.2
|
Certification
of Principal Financial Officer, pursuant to 18 U.S.C. 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
Filed
herewith.
|
/s/ Wei Li | November 15, 2006 | Chief Executive Officer and Chairman of the Board of Directors | ||
Wei Li | (Principal Executive Officer) | |||
/s/ Lian jun Luo | November 15, 2006 | Chief Financial Officer and Director | ||
Lian jun Luo | (Principal Financial Officer and Principal Accounting Officer) |